IL1B and Alzheimer disease: Elmonem et al. reported that zinc oxide nanoparticles ameliorate the neurotoxic effects of AD by decreasing IL-1β, TNF-α, and acetylcholinesterase activity and increasing glutathione production (Abd Elmonem et al., 2023).